NCT02599259 - Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Stroke

Interventions

DEVICE

Monitored (M+)

Patients assigned to the intervention arm will use the AiCure Platform to monitor ingestion of all prescribed doses of oral anticoagulants. If a patient misses a dose, takes an incorrect dose, or their data are flagged for suspicious activity, they will be contacted by the Study Coordinator or AiCure study team.

Trial Locations (1)

10467

Montefiore Medical Center, New York